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Abstract
Background: Adiponectin is an adipocyte-derived hormone that acts as a marker of insulin sensitivity. Bloodspot sampling
by fingerstick onto filter paper may increase the feasibility of large-scale studies of the determinants of insulin sensitivity.
We first describe the validation of an enzyme-linked immunoassay (ELISA) for quantifying adiponectin from dried blood
spots and then demonstrate its application in a large trial (PROBIT).
Methods:We quantified adiponectin from 3-mm diameter discs (<3 mL of blood) punched from dried blood spots obtained
from: i) whole blood standards (validation); and ii) PROBIT trial samples (application) in which paediatricians collected blood
spots from 13,879 children aged 11.5 years from 31 sites across Belarus. We examined the distribution of bloodspot
adiponectin by demographic and anthropometric factors, fasting insulin and glucose.
Results: In the validation study, mean intra-assay coefficients of variation (n = 162) were 15%, 13% and 10% for ‘low’
(6.78 mg/ml), ‘medium’ (18.18 mg/ml) and ’high’ (33.13 mg/ml) internal quality control (IQC) samples, respectively; the
respective inter-assay values (n = 40) were 23%, 21% and 14%. The correlation coefficient between 50 paired whole
bloodspot versus plasma samples, collected simultaneously, was 0.87 (95% CI: 0.78 to 0.93). Recovery of known quantities of
adiponectin (between 4.5 to 36 mg/ml) was 100.3–133%. Bloodspot adiponectin was stable for at least 30 months at 280uC.
In PROBIT, we successfully quantified fasting adiponectin from dried blood spots in 13,329 of 13,879 (96%) children. Mean
adiponectin (standard deviation) concentrations were 17.34 mg/ml (7.54) in boys and 18.41 mg/ml (7.92) in girls and were
inversely associated with body mass index, fat mass, triceps and subscapular skin-fold thickness, waist circumference, height
and fasting glucose.
Conclusions: Bloodspot ELISA is suitable for measuring adiponectin in very small volumes of blood collected on filter paper
and can be applied to large-scale studies.
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Introduction
There is substantial interest in large-scale epidemiology studies
of the genetic and environmental determinants of insulin
resistance,[1–10] which may inform strategies for the prevention
of insulin resistance and its sequelae. [11] Adiponectin is an
adipocyte-derived hormone that circulates in high concentrations
in humans, moderating glycemia, lipidemia, endothelial dysfunc-
tion and proinflammatory mechanisms.[12–15] Higher levels of
circulating adiponectin are inversely associated with obesity,
especially central obesity, as well as hyperlipidemia, insulin
resistance, b–cell dysfunction, and intramyocellular lipid accumu-
lation,[16–23] both in children and in adults with risk of
cardiovascular events.[13,24–26] These relationships, the fact that
adiponectin levels are not materially affected by time of day or
eating, and the low long-term intra-individual variation, [27]
indicate that adiponectin could act as an integrated quantitative
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measure of insulin sensitivity for use in epidemiology studies.
[20,28].
Important challenges in large-scale epidemiology include non-
acceptance of venepuncture especially by children and/or their
parents; the costs, safety and logistics of serum or plasma
separation by centrifugation; and frozen storage and transport of
aliquots. An alternative procedure to venepuncture involves
capillary puncture of the finger pulp to collect whole blood spots
that are then dried on filter paper. [29,30] The major advantages
of dried blood spot sampling are minimal training, lower cost than
venepuncture, acceptability to parents and children, [30] negligi-
ble processing requirements (cards must be air dried), low
biohazard risk because samples cannot shatter or leak, and the
ease of storage and transport of filter paper cards. [29,31].
As well as large-scale use of dried blood spots in paediatric
screening programs for rare inherited disorders, there is
widespread interest in developing and validating a wide range of
bloodspot assays, [32] including adiponectin, [33] for population
research. We first describe the validation of an enzyme-linked
immunoassay (ELISA) for quantification of adiponectin from dried
blood spots, which offers the important advantage that results can
be read on universally available microtitre plate readers, without
the need for regulatory approvals to use radioisotopes or more
specialised and costly measuring equipment. Development and
validation of an ELISA blood spot assay offers a simple,
convenient and novel alternative method of measuring adiponec-
tin in large-scale epidemiology studies in a wide range of settings.
We then show the successful practical application of our dried
blood spot assay in a large-scale, multicentre trial (the Promotion
of Breastfeeding Intervention Trial, PROBIT [34]) by describing
the distribution of fasting adiponectin levels by demographic and
anthropometric factors, fasting insulin and glucose measured in
over 13,000 children aged 11.5 years from 31 polyclinics
distributed across the Republic of Belarus.
Materials and Methods
Validation Study
Materials. Blood samples were collected onto Food and
Drug Administration approved Whatman 903 filter paper cards,
[35] pre-printed with eight 10 mm diameter circles, standardized
to absorb blood in a homogeneous manner so that uniform
punches from any section of the sample yield the same quantity of
blood. [36] We used an existing commercial kit, originally
designed for use on serum or plasma (adiponectin human ELISA,
EIA4177, DRG International Inc, New Jersey). The kit quantifies
adiponectin using a solid phase, two-site enzyme-linked immuno-
assay, based on the direct sandwich technique in which two
monoclonal antibodies are directed against separate antigenic
determinants on the adiponectin molecule. Instruments used
included an automatic filter paper card puncher (Wallac DBS
(Dried Blood Spot) Puncher, product number: 1296-071, Perkin
Elmer, USA), a microplate washing device (DELFIA Washer-
Diskremove, product number: 1296-0010 Perkin Elmer, USA), a
plate shaker (DELFIA Plateshaker, product number:1296-003,
Perkin Elmer, USA) and a microplate reader (VICTOR3
Multilabel Reader, product number: 1420-012, Perkin Elmer,
USA).
Preparation of bloodspot adiponectin standards and
internal quality control samples. We prepared whole blood
adiponectin standards and internal quality control samples to
minimize matrix differences and maximize comparability between
the standards, quality control samples and the trial samples. For
the standards, we collected whole blood by phlebotomy from a
volunteer, centrifuged it, established the adiponectin concentration
in plasma, double diluted it in phosphate buffered saline (PBS) and
1% human albumin to obtain levels of 3.75, 7.5, 15.0 and
Figure 1. Typical calibration curve. Whole bloodspot adiponectin
standards at 3.75, 7.5, 15.0, 30.46 mg/ml.
doi:10.1371/journal.pone.0071315.g001
Table 1. Intra- and inter-assay imprecision of dried whole bloodspot adiponectin assays.
Sample Mean adiponectin (mg/ml)
Mean standard deviation of
repeated measures Coefficient of variation
Intra-assay (n = 162)
Low 6.78 1.00 15%
Medium 18.18 2.41 13%
High 33.13 3.47 10%
Inter-assay (n = 40)
Low 6.78 1.54 23%
Medium 18.18 3.73 21%
High 33.13 4.53 14%
doi:10.1371/journal.pone.0071315.t001
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30.46 mg/ml (top standard). We then mixed each dilution with
washed red blood cells (in proportions 60:40 for a 0.40
haematocrit) and applied drops to Whatman 903 filter paper.
Internal quality control samples were based on whole blood taken
from 3 volunteers (with low, medium and high values) that was
applied to Whatman 903 filter paper and the values assigned from
the mean of 24 replicates of the assay.
Assay procedure. All frozen blood spot cards (see sample
collection below) were brought to room temperature before being
removed from the plastic bags for assaying. For each child, one 3-
mm disc (< 3 mL of blood) was punched from the blood spots (of
the standards, quality control samples and the trial samples) using
an automatic puncher into 96-well microtitre plates, precoated
with a monoclonal anti-human adiponectin antibodies. Adipo-
nectin was extracted from the disc by overnight incubation in a
refrigerator with 300 mL of assay buffer (0.05 M Phosphosaline
containing 0.025 M EDTA, 0.08% Sodium Azide, 1% BSA).
Following incubation, the wells were washed 3 times with wash
solution (Tris-buffered saline) to remove unbound enzyme labelled
antibody and 20 mL pre-titered biotinylated mouse anti-human
adiponectin antibody was added to each well and incubated for 2
hours at room temperature on the plate shaker. Bound conjugate
was detected by incubation with 100 mL of enzyme solution (pre-
filtered streptavidin-horseradish peroxidise conjugate) and 100 mL
of substrate solution (3,39,5959-tetramethylbenzidine in buffer,
TMB), before adding 100 mL of stop solution (0.3 M HCl) to
terminate the peroxidase/TMB reaction and give a colorimetric
endpoint that was read within 5 minutes at 450 and 590 nm. The
difference in absorbance units was plotted against the assigned
concentration in mg/ml of the whole blood filter paper standard
values using a sigmoidal 4- or 5-parameter logistic equation on the
log scale on both x and y axes. The concentration of the samples
was read from the fitted standard curve. Samples with adiponectin
levels above 40 mg/mL but#60 mg/ml (3.3%) were reanalyzed by
a 1:2 dilution and those .60 mg/mL (0.7%) reanalyzed by a 1:4
dilution. Adiponectin values between the top standard (30 mg/mL)
and 40 mg/ml were assigned the observed value, after determining
amongst a sample of 69 children that repeating the assay using
double dilution for these levels made no material difference to the
observed values. Samples with adiponectin levels less than the
lowest standard (3.75 mg/ml, 0.8%) were repeated.
Inter- and intra-assay imprecision. Inter- and intra-assay
imprecision was assessed using internal quality control samples at
three levels: ‘low’ (6.78 mg/ml), ‘medium’ (18.18 mg/ml) and ’high’
(33.13 mg/ml). Intra-assay imprecision was established from
duplicate analysis (n = 162) and inter-assay imprecision was
determined from 40 separate runs over a period of 29 months.
Inter-assay samples were run in duplicate and both intra- and
inter-assay imprecision include between-spot extraction variations.
Stability. To assess stability at280uC over the long-term, the
whole blood samples used to provide the internal quality controls
were spotted onto Whatman 903 cards, cut into strips containing
one blood spot per strip, and frozen at 280uC. Initially with every
run (for 34 weeks) and then at regular intervals for a total period of
30 months, a different strip was thawed (to ensure levels were
based on only one thaw) and the blood spot adiponectin value
measured in duplicate.
Recovery. We assessed recovery by diluting plasma with an
adiponectin concentration of 36 ug/ml with buffered saline to
concentrations of 18, 9, 4.5 and 0 ug/ml, mixing the plasma with
erythrocytes in the ratio 60:40, spotting onto Whatman 903 cards
and determining the values retrieved after applying the blood spot
assay protocol in triplicate.
Comparison between plasma and dried blood spots. We
compared adiponectin concentrations in plasma (measured using
the adiponectin human ELISA, EIA4177, DRG International Inc,
New Jersey) with concentrations measured from dried blood spots,
Figure 2. Stability of adiponectin concentrations (at A. low, B.
medium and C. high values) measured from dried blood spots
and stored at 2806C for 30 months. Adiponectin concentrations of
internal quality control (IQC) bloodspots (low, medium and high values)
analysed at regular intervals over 30 months. For the ‘low’ IQC sample
(Fig. 2A), the middle red line is the mean adiponectin concentration and
the upper and lower red lines are the 95% reference range (calculated
from the standard deviation of 24 replicates); the respective lines
showing the mean and 95% reference range for the ‘medium’ (Fig. 2B)
and ‘high’ (Fig. 2C) IQC samples are also shown.
doi:10.1371/journal.pone.0071315.g002
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collected simultaneously from 50 children in Minsk. Whole blood
samples were allowed to stand at room temperature for 2–4 hours
then centrifuged at 3000 rpm for 5 minutes before separating the
plasma. Blood spots and plasma were stored at 280uC and
brought to room temperature before assaying, performed in
duplicate for both plasma and dried blood spot samples.
Figure 3. Comparison of adiponectin concentrations measured from 50 paired plasma and whole bloodspot samples.
doi:10.1371/journal.pone.0071315.g003
Figure 4. Bland-Altman plot for plasma adiponectin minus bloodspot adiponectin values in 50 paired samples. Limits of agreement
(reference range for the difference): 214.8 to 0.68 mg/ml. Mean difference in adiponectin between plasma minus blood spot samples: 27.1 mg/ml
(95% CI: 28.2 to 26.0). Range of average values: 6.7 to 39.8 mg/ml.
doi:10.1371/journal.pone.0071315.g004
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Application of Methods
Distribution of adiponectin by demographic and clinical
characteristics. We followed up 13,879 children aged 11.5
years (interquartile range 11.3–11.8 years) who were participants
in a multicentre trial of a breastfeeding promotion intervention
involving 31 polyclinics (39 paediatricians) located throughout the
Republic of Belarus. [34] Children who were eligible for the trial
(healthy, term newborns whose mother initiated breastfeeding)
were originally recruited at birth between 1996 and 1997, [34] and
have been followed up intermittently since then, including the
11.5 year follow-up reported here between 2008–2010. At 11.5
years, dried blood spots were collected from the children as
described below. The children also had fasted insulin measured
from dried blood spots as described previously, [37] whole blood
fasting glucose measured by glucometer (Roche ACCU-CHEK
Advantage meter system, F. Hoffmann-La Roche AG, Basel,
Switzerland) and the following physical measurements (amongst
others not reported here) were made by study paediatricians:
Tanner pubertal stage, height, weight, body mass index (BMI,
weight (kg)/height (m)2), skinfold thicknesses, waist circumference
and leg-to-leg bioimpedence (Tanita TBF 300GS, Tanita Europe
BV, Netherlands) for calculation of fat-mass. Birthweight had been
collected when the children were recruited into the trial at birth in
1996/1997. [34].
Sample collection. The protocol for sample collection,
quality assurance processes, and the detailed training received by
the paediatricians in obtaining blood spots, has been reported in
detail elsewhere. [37] In brief, children in the PROBIT trial
follow-up were asked to fast for at least 8 hours. Up to 8 drops of
fingertip capillary blood were obtained by trained paediatricians
using a sterile, single-use disposable lancet device (Roche ACCU-
CHEK Safe-T-Pro Plus lancet, Roche Diagnostics Corp.,
Indianapolis, USA) and applied to the pre-printed circles to form
one discrete spot per drop, following specific guidelines. [35,38]
The blood spots were air-dried and then placed in low gas-
permeable zip-closure plastic bags with desiccant packages. [36]
These were stored initially in –20uC freezers at the 31 polyclinics,
prior to transfer in cool boxes packed with freezer packs to 280uC
freezers at the central laboratory in Minsk. The samples were
stored at 220uC for a median of 1.6 months (IQR 1.0–5.0
months) and at 280uC for a median of 16.9 (IQR 11.9–20.2)
months. At the central laboratory in Minsk, 432 samples were
assayed in 5 plates per week, using 4 separate assay lots. Assays
were run in singleton and repeated if they failed quality control
parameters. It took 34 weeks to complete the study.
Audit. Once data collection was complete, we conducted
audit visits to assess the inter-observer reproducibility, an
important step given that the pediatricians were not blinded to
randomization status. For each of the 39 pediatricians, 1–5
children were randomly selected for the audit, for a total of 127
audited children with baseline and repeat adiponectin values. So
that all children seen in follow-up were eligible for selection, the
Table 2. Recovery of adiponectin from five different dried blood spot concentrations.
Adiponectin in whole blood (mg/ml) Adiponectin in dried blood (mg/ml) Recovery, %
0 0.34 –
4.5 5.84 130%
9.0 9.025 100.3%
18 20.14 111.9%
36 48.04 133%
doi:10.1371/journal.pone.0071315.t002
Figure 5. Number of blood spots per child collected in the PROBIT study when the children were aged 11.5 years.
doi:10.1371/journal.pone.0071315.g005
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Table 3. Adiponectin levels in boys and girls by demographic and clinical characteristics, N = 13,329.
Adiponectin levels (mg/ml) and age-adjusted difference in adiponectin
(95% CI) per unit of demographic/clinical variable
N Girls N Boys
p for sex
interaction
Age group (yrs)
10 – ,11 407 17.6 (7.3) 422 17.0 (7.5)
11 – ,12 4949 18.6 (7.9) 5191 17.5 (7.6)
12 – ,13 1012 18.2 (7.9) 1108 17.0 (7.3)
13 – ,14 110 14.0 (7.3) 130 13.8 (5.1)
Change in adiponectin per yeara 20.50 (21.84, 0.83) 20.61 (21.35, 0.13) 0.77
Location
Rural 2738 18.6 (7.9) 2860 17.5 (7.8)
Urban 3740 18.3 (7.9) 3991 17.2 (7.3)
Difference in adiponectina 0.34 (21.00, 1.68) 0.33 (20.78, 1.45) 0.96
East 3114 18.3 (7.9) 3179 17.3 (7.5)
West 3364 18.5 (7.9) 3672 17.3 (7.5)
Difference in adiponectina 20.17 (21.48, 1.14) 20.02 (21.16, 1.11) 0.60
Tanner stage by breast (girls)/genitalia (boys)
I 745 18.4 (7.5) 897 16.9 (7.3)
II 3323 18.7 (8.1) 3699 17.6 (7.7)
III 2080 18.1 (7.8) 1995 17.0 (7.3)
IV/V 325 17.4 (6.9) 252 17.9 (7.9)
Change in adiponectin per categorya 20.37 (20.87, 0.14) 20.001 (20.61, 0.61) 0.20
Tanner stage by pubic hair assessment
I 1819 18.6 (8.0) 3440 17.6 (7.7)
II 3035 18.5 (8.0) 2808 17.3 (7.4)
III 1434 17.9 (7.6) 546 16.4 (6.8)
IV/V 185 18.7 (7.0) 49 15.0 (6.4)
Change in adiponectin per categorya 20.24 (20.71, 0.23) 20.50 (20.90, 20.10) 0.15
Body mass index (kg/m2)b
Normal weight 5627 18.70 (7.93) 5668 17.61 (7.57)
Overweight 607 17.21 (7.68) 738 16.49 (7.38)
Obese 240 14.97 (6.85) 439 15.53 (7.02)
Change in adiponectin per categorya 21.73 (22.06, 21.39) 21.06 (21.42, 20.70) 0.003
Fat mass (kg)
,90th centile 5913 18.6 (7.9) 6128 17.5 (7.5)
$90th centiled 652 16.4 (7.5) 688 15.9 (7.3)
Difference in adiponectina 22.19 (22.65, 21.72) 21.60 (22.29, 20.90) 0.10
Triceps thickness (mm)
,90th centile 5900 18.6 (8.0) 6149 17.5 (7.5)
$90th centiled 724 16.5 (7.0) 699 16.4 (7.3)
Difference in adiponectina 22.15 (22.93, 21.38) 21.03 (21.71, 20.35) 0.004
Subscapular thickness (mm)
,90th centile 6214 18.5 (7.9) 6567 17.4 (7.5)
$90th centiled 258 15.1 (6.4) 282 15.5 (7.0)
Difference in adiponectina 23.40 (24.14, 22.67) 21.91 (22.64, 21.19) 0.001
Waist circumference (cm)
,90th centile 6106 18.6 (7.9) 6704 17.5 (7.5)
$90th centilec 369 15.6 (7.0) 305 15.3 (7.2)
Difference in adiponectina 22.23 (22.67, 21.79) 21.53 (22.21, 20.85) 0.08
Height (cm)e
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audit was carried out after completion of primary data collection,
an average of 1.3 years (range 0.2 to 2.4 years) after the initial
clinic visit. The audit was carried out by one of five Minsk-based
pediatricians not involved in primary data collection and blinded
to the measures obtained at the initial visit but not to experimental
or control status. Because of the time elapsed between the audit
and initial visits, results were compared using Spearman correla-
tion coefficients.
Ethics. The study received ethical approval from McGill
University Health Centre Research Ethics Board; the Human
Subjects Committee at Harvard Pilgrim Health Care; and the
Avon Longitudinal Study of Parents and Children Law and Ethics
Committee. The conduct of the study was also approved by the
Ministry of Health of the Republic of Belarus. A parent or legal
guardian provided written informed consent and all children
provided written assent. The trial registration number is
ISRCTN37687716 for Current Controlled Trials and
NCT01561612 for Clinicaltrials.gov.
Statistical analysis. Calibration curves were constructed
with Multicalc software (Wallac, Turku, Finland), using the log
scale for both x and y axes. To assess the relationship between
adiponectin values from plasma versus whole blood spot samples
collected simultaneously, we computed the correlation coefficient
(95% confidence interval) and constructed a Bland-Altman plot of
the difference between the plasma and bloodspot adiponectin
values (y-axis) against the mean of these two values (x-axis). Using
data from the PROBIT study, we performed linear regression
accounting for clustering by polyclinic to investigate relationships
of adiponectin levels with child age, location of polyclinic (urban/
rural; East/West Belarus), puberty as measured by Tanner stage,
measures of general (BMI, fat mass, peripheral (triceps skinfold
thickness) and central (subscapular skinfold thickness, waist
circumference) adiposity, height, birthweight and fasting glucose,
and insulin. We calculated sex-specific associations and performed
a likelihood ratio test for interactions between sex and the
demographic, glucose, insulin and anthropometric factors on
adiponectin. We also performed a likelihood ratio interaction test
Table 3. Cont.
Adiponectin levels (mg/ml) and age-adjusted difference in adiponectin
(95% CI) per unit of demographic/clinical variable
N Girls N Boys
p for sex
interaction
Q1 2036 18.9 (8.1) 2013 17.7 (7.5)
Q2 1627 18.3 (8.0) 1822 17.7 (7.6)
Q3 1460 18.2 (7.9) 2022 17.1 (7.5)
Q4 1355 17.9 (7.5) 992 16.5 (7.4)
Change in adiponectin per 10 cma 20.47 (20.86, 20.07) 20.49 (20.85, 20.14) 0.79
Birthweight (g)f
Q1 1819 18.0 (7.9) 1748 17.0 (7.4)
Q2 1466 18.4 (7.8) 1851 17.4 (7.5)
Q3 1579 18.6 (8.0) 1776 17.5 (7.6)
Q4 1614 18.7 (7.9) 1476 17.4 (7.6)
Change in adiponectin per 100ga 0.07 (0.03, 0.11) 0.03 (20.02, 0.08) 0.16
Glucose(mmol/l)
Q1 1569 19.5 (8.0) 1979 17.9 (7.5)
Q2 1601 19.1 (8.1) 1337 17.9 (7.9)
Q3 1521 17.9 (7.8) 1628 17.3 (7.5)
Q4 1778 17.3 (7.6) 1902 16.5 (7.3)
Change in adiponectin per SD increase
in glucosea
20.55 (20.89, 20.22) 20.55 (20.89, 20.21) 0.96
Insulin (mU/L)
Q1 1570 17.6 (7.6) 1626 16.8 (7.2)
Q2 1578 18.6 (7.8) 1630 17.4 (7.4)
Q3 1578 19.0 (8.3) 1628 17.7 (7.6)
Q4 1582 18.4 (7.8) 1638 17.7 (7.9)
Change in adiponectin per SD increase
in insulina
0.20 (20.03, 0.44) 0.004 (20.19, 0.20) 0.07
SD= standard deviation; CI = confidence interval.
aLinear regression coefficient and 95% CI (age-adjusted, accounting for clustering by polyclinic).
bNormal weight, overweight and obese as defined by the International Obesity Task Force BMI cut-offs. [44].
cCentiles derived from NHANES European age and sex-specific thresholds (reference) [45].
dCentile derived from sample.
eQuartiles derived from NHSR age-and sex-specific thresholds [46].
fQuartiles derived from sample.
doi:10.1371/journal.pone.0071315.t003
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of whether the association of adiponectin with insulin levels varied
by whether the children were overweight/obese versus normal
weight. Analyses were undertaken using Stata version 11
(StataCorp LP, Texas) and SAS version 9.3 (SAS Institute, Inc.,
Cary, North Carolina).
Results
A typical calibration curve is shown in Figure 1. The precision
of the dried blood spot extraction and consecutive determination
by ELISA is summarised in Table 1. Mean intra-assay (n = 162)
coefficients of variation were 15%, 13% and 10% for ‘low’
(6.78 mg/ml), ‘medium’ (18.18 mg/ml) and ’high’ (33.13 mg/ml)
IQC samples, respectively; the respective inter-assay values
(n = 40) were 23%, 21% and 14%.
The results of the 30 month long-term stability study at 280uC
are shown in Figure 2. Over the 30 months, most values were
within the 95% reference range established from 24 replicates of
the time 0 value, although there were month-by-month fluctua-
tions in line with the inter-assay imprecision of measurements. In
linear regression analyses, adjusted for lot number, there was no
evidence of any association between storage time at 280uC and
levels of adiponectin for the low (change in adiponectin levels per
month = 0.04 mg/ml; 95% CI: 20.04 to 0.12; p= 0.33), medium
(0.05 mg/ml; 95% CI: 20.12 to 0.22; p = 0.53), or high (0.07 mg/
ml; 95% CI: 20.30 to 0.44; p= 0.70) internal quality control
samples.
Comparison of Samples and Recovery
Comparison of 50 paired fasted whole bloodspots and plasma
samples samples collected simultaneously gave a correlation
coefficient of 0.87 (95% CI: 0.78 to 0.93) (Figure 3), the range
of plasma values being 3.9 to 35.7 mg/ml. The Bland Altman plot
shows that the 95% limits of agreement were between 214.8 to
0.68 mg/ml with a mean difference (plasma minus blood spot)
across the range of values of 27.1 mg/ml (CI 28.2 to 26.0),
indicating that blood spot measurement of adiponectin was higher
on average than plasma measurement (Figure 4). Inference was
similar when the Bland-Altman plot was based on the ratio of
bloodspot to plasma adiponectin values (Figure S1) Recovery of
known quantities of adiponectin (between 4.5 to 36 mg/ml) was
100.3–133% (Table 2).
Associations of Adiponectin with Demographic and
Clinical Variables
Out of a total of 13,879 children who were approached, 13,547
(97.6%) provided at least one acceptable dried blood spot sample
(Figure 5). Amongst the 13,547 children, the paediatricians
collected a median of 8 blood spots, with 85.1% (11,534) of
children assessed by the central laboratory in Minsk as having
had 8 acceptable quality blood spots collected. We assayed a total
of 13,329 children who fasted for 8 or more hours for
adiponectin.
Table 3 shows adiponectin levels in boys and girls by
demographic and clinical variables. Mean adiponectin (standard
deviation) concentrations were 17.34 mg/ml (7.54) in boys and
18.41 mg/ml (7.92) in girls (p for gender difference,0.001).
Concentrations of adiponectin were inversely associated with
Tanner stage by public hair assessment (boys). Adiponectin
concentrations were also inversely associated with body mass
index, fat mass, mean triceps and subscapular thicknesses, waist
circumference, height and fasting glucose concentrations. There
was evidence of an interaction between sex and body mass index,
mean triceps thickness and mean subscapular thickness (p for
interaction,0.01), although the direction of the effects in both
boys and girls was inverse. There was little evidence that the null
association of adiponectin with insulin levels varied by whether
the children were overweight/obese versus normal weight (p for
interaction = 0.15). The audit results between initial clinic results
and blinded repeat (audit) measures of adiponectin showed a
Spearman correlation coefficient of 0.33.
Table 4. Comparison of adiponectin levels measured in PROBIT with other studies in children of a similar age.
Adiponectin levels (mg/ml)
Study (ordered by subjects’
age)
Mean age, years (SD, unless
otherwise stated) Number Mean/median SD (unless otherwise stated)
Girls
Ong [42] 8.2 (8.1–8.2)a 390 14.0 11.4–17.6b
PROBIT 11.5 (11.3–11.8)a 6478 18.4 7.9
Okada [39] 11.6 (1.5) 139 15.4 7.1
Punthakee [41] 13 235 10.9 10.4–11.4c
Singhal [40] 14.9 (0.9) 160 7.6 5.6–10.6b
Boys
Ong [42] 8.2 (8.1–8.2)a 449 13.0 11.1–16.0b
PROBIT 11.5 (11.3–11.8)a 6851 17.35 7.5
Okada [39] 11.6 (1.5) 144 13.7 6.1
Punthakee [41] 13 269 9.1 8.6–9.5c
Singhal [40] 15.0 (0.9) 134 6.4 4.7–9.5b
SD= standard deviation; m=months;
amedian (interquartile range);
binterquartile range;
c95% CI.
doi:10.1371/journal.pone.0071315.t004
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Discussion
We have shown that adiponectin in dried blood spots is stable
and can be reliably quantified on a very large-scale with modest
infrastructure, making the method useful for population-based
studies of adiposity, insulin resistance, diabetes and cardiovascular
risk in a variety of settings. Our data support a previous paper
reporting on the quantification of adiponectin in dried blood spots
from neonates in a small retrospective case-control study (n= 124).
[33] The advantages of fingerstick blood collection onto filter
paper include ease of collection, processing, storage and transport,
thus providing a valuable research tool for large epidemiology
studies, particularly those that are geographically dispersed.
The dried blood spot methods showed acceptable analytical
performance characteristics and good agreement with the
conventional plasma adiponectin assay across the distribution of
adiponectin values. There are several sources of variation unique
to bloodspot sampling and the assay that could explain differences
between bloodspot versus plasma. For example, proper placement
of the whole blood sample on the filter paper is critical and errors
can be introduced if blood is blotted or smeared rather than drawn
onto the filter paper by capillary action. [32] We minimised this
source of error by rigorous training and regular feedback. [37]
Pre-printed circles on the filter paper were used to help guide the
paediatricians to position the bloodspot. To maximise stability,
samples were placed in zip-closure bags packed with dessicant and
frozen at 220uC promptly after drying to reduce the chances of
degradation. These sources of variation are not seen with
venepuncture sampling and the coefficients of variation reported
in Table 1 were larger than those reported in the adiponectin kit
insert (adiponectin human ELISA, EIA4177, DRG International
Inc, New Jersey): 7.4%, 0.9% and 1.8% for ‘low’ (17.73 mg/ml),
‘medium’ (29.13 mg/ml) and ’high’ (39.10 mg/ml) serum samples,
respectively; the respective inter-assay values were 8.4%, 2.4% and
6.2%. The haematocrit level was set to 0.4 in the standards but not
adjusted for in each sample; any sample differences would
introduce errors. The variation seen in Figure 2 is broadly in
line with the imprecision suggested in Table 1. Despite unique
sources of error, we achieved a good correlation between dried
blood spot versus plasma methods of measurement.
In our fieldwork study, we showed that taking capillary blood
samples from children is feasible on a large scale, since only 2.4%
(n= 332) of 13,879 children approached did not provide a useable
sample and the paediatricians were able to take a median of 8
acceptable blood spots amongst those who were sampled.
Although we documented slightly greater imprecision than would
be expected in plasma or serum samples, our analysis of
established associations of adiponectin levels with gender, adipos-
ity measures, glucose and height, were in line with previously
published results.[39–42] We did not observe an association of
adiponectin with fasting insulin levels in our population of 11.5
year olds, in line with others indicating a complex relationship at
this age. [41,42] The mean values in girls and boys that we
observed were slightly higher, but in line with other reports (given
age, setting, population and sampling variation) (Table 4).[39–
42].
The advantages of filter paper capillary blood sampling,
combined with the acceptable analytical performance character-
istics of the dried blood spot assays, makes the approach ideal for
large-scale epidemiologic applications, including studies of chil-
dren, whenever the acceptability, stability, cost and safety of liquid
sample collection and transportation to distant laboratories may be
limiting factors (which may not be the case, however, for small and
medium sized studies that are geographically contained). There
are caveats, as we have previously pointed out, [37] including the
need for adequate training for those taking the bloodspot samples
onto filter paper, to avoid several sources of error, and the fact that
we have developed the dried bloodspot assay for research and not
clinical use, which would require additional investigation. [43].
Supporting Information
Figure S1 Bland-Altman plot for the ratio of bloodspot
to plasma adiponectin values in 50 paired samples.Mean
ratio of bloodspot to plasma adiponectin values: 1.57 (95% CI:
1.47 to 1.67). Range of ratio values: 0.97 to 2.39.
(PPTX)
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